Mekiri Bio, Inc.
Biotechnology company · Boston, Massachusetts, United States
Mekiri Bio, Inc. is a biotechnology company headquartered in Boston, Massachusetts, United States. Its earliest recorded incorporation is in 2025. It has reported private securities offerings to the US SEC, most recently $1 million sold in a notice filed in 2025.
Mekiri Bio at a glance
What does Mekiri Bio do?
Private fundraising reported to the SEC
1 Form D notice; the most recent reported $1 million sold (2025).
Frequently asked questions about Mekiri Bio
Where is Mekiri Bio headquartered?
Mekiri Bio, Inc. is headquartered in Boston, Massachusetts, United States.
What does Mekiri Bio do?
Mekiri Bio, Inc. is a biotechnology company.
When was Mekiri Bio founded?
The earliest incorporation on record for Mekiri Bio, Inc. is in 2025, according to public company registers.
Similar companies
- Syntis Bio, Inc.Boston, Massachusetts, United States
- Strand Therapeutics Inc.Boston, Massachusetts, United States
- Pear Therapeutics, Inc.Boston, Massachusetts, United States
- Aura Biosciences, Inc.Boston, Massachusetts, United States
- Holobiome, Inc.Boston, Massachusetts, United States
- Leuko Labs, Inc.Boston, Massachusetts, United States
- Compass Therapeutics, Inc.Boston, Massachusetts, United States
- Odyssey Therapeutics, Inc.Boston, Massachusetts, United States
Need a CRO or CDMO for your next study?
Compare transparent quotes from research and manufacturing partners, then contract once. Free for buyers.
Compare quotesLast updated 2026-09-23. Data licences